Icro Maremmani, Matteo Pacini & Angelo G. I. MaremmaniIcro Maremmani, Matteo Pacini & Angelo G. I. Maremmani. 2023. Dual Disorder Heroin Addicts. Dual Disorder Heroin Addicts
39
90
.
Anees Bahji, Marlon Danilewitz, Gustavo Vazquez & Scott Patten. (2021) The Prevalence of Cannabis Use Disorder Comorbidity in Individuals With Bipolar Disorder: A Systematic Review and Meta-Analysis. Canadian Journal of Addiction 12:3, pages 22-38.
Crossref
Javier I. de la Iglesia-Larrad, Carmen Barral, Nerea M. Casado-Espada, Rubén de Alarcón, Ana Maciá-Casas, Begoña Vicente Hernandez & Carlos Roncero. (2020) Benzodiazepine abuse, misuse, dependence, and withdrawal among schizophrenic patients: A review of the literature. Psychiatry Research 284, pages 112660.
Crossref
Oladipo A. Sowunmi, Gbolagade Amoo, Peter O. Onifade, Adegboyega Ogunwale & Emmanuel Babalola. (2019) Psychoactive substance use among outpatients with severe mental illness: A comparative study. South African Journal of Psychiatry 25.
Crossref
Manjunath Rajashekharaiah & Pravin Verma. (2016) COMPARISON OF SOCIODEMOGRAPHIC AND CLINICAL VARIABLES IN SCHIZOPHRENICS WITH AND WITHOUT SUBSTANCE ABUSE. Journal of Evolution of Medical and Dental Sciences 5:66, pages 4681-4686.
Crossref
Angelo Giovanni Icro Maremmani, Silvia Bacciardi, Nicole D. Gehring, Luca Cambioli, Christian Schütz, Hagop S. Akiskal, Kerry Jang & Michael Krausz. (2015) The impact of mood symptomatology on pattern of substance use among homeless. Journal of Affective Disorders 176, pages 164-170.
Crossref
Kostas N. FountoulakisKostas N. Fountoulakis. 2015. Bipolar Disorder. Bipolar Disorder
205
223
.
E Sherwood Brown, Prabha Sunderajan, Lisa T Hu, Sharon M Sowell & Thomas J Carmody. (2012) A Randomized, Double-Blind, Placebo-Controlled, Trial of Lamotrigine Therapy in Bipolar Disorder, Depressed or Mixed Phase and Cocaine Dependence. Neuropsychopharmacology 37:11, pages 2347-2354.
Crossref
Louisa Degenhardt, Wayne Hall, Michael Lynskey, Carolyn Coffey & George Patton. 2011. Marijuana and Madness. Marijuana and Madness
114
128
.
F. Kazour, J. Rouhayem, R. Chammay, R. Haddad, G. Haddad, X. Laqueille & S. Richa. (2011) Cannabis et trouble bipolaire : recherche d’une association à partir d’une revue de la littérature. Annales Médico-psychologiques, revue psychiatrique 169:5, pages 277-281.
Crossref
Matteo Pacini, Icro Maremmani, Mario Vitali, Marina Romeo, Patrizia Santini, Valeria Vermeil & Mauro Ceccanti. (2010) Cocaine Abuse in 448 Alcoholics. Addictive Disorders & Their Treatment 9:4, pages 164-171.
Crossref
Iain C. Anthony, Katherine E. Norrby, Tommy Dingwall, Frances W. Carnie, Tracey Millar, Juan Carlos Arango, Roy Robertson & Jeanne E. Bell. (2010) Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers. Brain 133:12, pages 3685-3698.
Crossref
Icro Maremmani, Matteo Pacini, Francesco Lamanna, Pier Paolo Pani, Giulio Perugi, Joseph Deltito, Ihsan M. Salloum & Hagop Akiskal. (2014) Mood Stabilizers in the Treatment of Substance Use Disorders. CNS Spectrums 15:2, pages 95-109.
Crossref
Matteo Pacini, Icro Maremmani, Mario Vitali, Patrizia Santini, Marina Romeo & Mauro Ceccanti. (2009) Affective temperaments in alcoholic patients. Alcohol 43:5, pages 397-404.
Crossref
Icro Maremmani, Giulio Perugi, Matteo Pacini & Hagop S. Akiskal. (2006) Toward a unitary perspective on the bipolar spectrum and substance abuse: Opiate addiction as a paradigm. Journal of Affective Disorders 93:1-3, pages 1-12.
Crossref
Monique Konings & Hari D Maharajh. (2006) Cannabis use and mood disorders: Patterns of clinical presentations among adolescents in a developing country. International Journal of Adolescent Medicine and Health 18:2.
Crossref
C. H. Ashton, P. B. Moore, P. Gallagher & A. H. Young. (2016) Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. Journal of Psychopharmacology 19:3, pages 293-300.
Crossref
Mark S. Bauer, Lori Altshuler, Denise R. Evans, Thomas Beresford, William O. Williford & Richard Hauger. (2005) Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. Journal of Affective Disorders 85:3, pages 301-315.
Crossref
Icro Maremmani, Matteo Pacini, Giulio Perugi & Hagop S Akiskal. (2004) Addiction and the Bipolar Spectrum. Addictive Disorders & Their Treatment 3:4, pages 156-164.
Crossref
Frances R. Levin & Grace Hennessy. (2004) Bipolar disorder and substance abuse. Biological Psychiatry 56:10, pages 738-748.
Crossref
Louisa Degenhardt, Wayne Hall, Michael Lynskey, Carolyn Coffey & George Patton. 2009. Marijuana and Madness. Marijuana and Madness
54
74
.
Dominic Wake. 2004. Mental Health Nursing. Mental Health Nursing
260
272
.
Louisa Degenhardt, Wayne Hall & Michael Lynskey. (2003) Exploring the association between cannabis use and depression. Addiction 98:11, pages 1493-1504.
Crossref
Amanda J Gruber & Harrison G PopeJr.Jr.. (2002) Marijuana use among adolescents. Pediatric Clinics of North America 49:2, pages 389-413.
Crossref
EVARISTO O. AKERELE & FRANCES R. LEVIN. (2002) Substance Abuse Among Patients with Schizophrenia. Journal of Psychiatric Practice 8:2, pages 70-80.
Crossref
Roger D. Weiss, Shelly F. Greenfield & Grace O'Leary. 2002. Substance Misuse in Psychosis. Substance Misuse in Psychosis
207
226
.
Frederick Cassidy, Eileen P Ahearn & Bernard J Carroll. (2008) Substance abuse in bipolar disorder. Bipolar Disorders 3:4, pages 181-188.
Crossref
J. Hättenschwiler, P. Rüesch & J. Modestin. (2001) Comparison of four groups of substance‐abusing in‐patients with different psychiatric comorbidity. Acta Psychiatrica Scandinavica 104:1, pages 59-65.
Crossref
E Sherwood Brown, Trisha Suppes, Bryon Adinoff & Nancy Rajan Thomas. (2001) Drug abuse and bipolar disorder: comorbidity or misdiagnosis?. Journal of Affective Disorders 65:2, pages 105-115.
Crossref
P. Phillips. (2008) Substance misuse, offending and mental illness: a review. Journal of Psychiatric and Mental Health Nursing 7:6, pages 483-489.
Crossref
Ihsan M Salloum & Michael E Thase. (2002) Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disorders 2:3p2, pages 269-280.
Crossref
Kn Roy Chengappa, Joseph Levine, Samuel Gershon & David J Kupfer. (2008) Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry. Bipolar Disorders 2:3, pages 191-195.
Crossref
Susan C. Sonne & Kathleen T. Brady. (1999) SUBSTANCE ABUSE AND BIPOLAR COMORBIDITY. Psychiatric Clinics of North America 22:3, pages 609-627.
Crossref
Roger D. Weiss, Lisa M. Najavits & Shelly F. Greenfield. (1999) A Relapse Prevention Group for Patients with Bipolar and Substance Use Disorders. Journal of Substance Abuse Treatment 16:1, pages 47-54.
Crossref
Alan C Swann. (1997) Manic-Depressive Illness and Substance Abuse. Psychiatric Annals 27:7, pages 507-511.
Crossref
Jiri Modestin, Christine Nussbaumer, Kathrin Angst, Paul Scheidegger & Daniel Hell. (1997) Use of potentially abusive psychotropic substances in psychiatric inpatients. European Archives of Psychiatry and Clinical Neuroscience 247:3, pages 146-153.
Crossref
L. Daini, M. R. Capone, T. Agueci, M. Aglietti, O. Zolesi & I. Maremmani. 1995. Drug Addiction and Related Clinical Problems. Drug Addiction and Related Clinical Problems
69
77
.
Stephen M. Strakowski, Susan L. McElroy, Paul W. KeckJr.Jr. & Scott A. West. (2004) The Co-Occurrence of Mania with Medical and other Psychiatric Disorders. The International Journal of Psychiatry in Medicine 24:4, pages 305-328.
Crossref
Jeanette Smith & Stephen Hucker. (2018) Schizophrenia and Substance Abuse. British Journal of Psychiatry 165:1, pages 13-21.
Crossref
Roger D. Weiss & Daniel A. Collins. (2010) Substance Abuse and Psychiatric Illness. The American Journal on Addictions 1:2, pages 93-99.
Crossref
K. T. Mueser, P. R. Yarnold & A. S. Bellack. (2007) Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatrica Scandinavica 85:1, pages 48-55.
Crossref
G Thornicroft, G Meadows & P Politi. (2020) Is “cannabis psychosis” a distinct category?. European Psychiatry 7:6, pages 277-282.
Crossref
W. E. Platz, J. Böning, W. Wesemann, N. Weiner, A. Hartmann, J. Deckert & C. H. Gleiter. 1993. Neuro-Psychopharmaka. Neuro-Psychopharmaka
125
226
.
G. Knecht, H. Schanda, P. Földes & E. Gabriel. 1991. Fortschritte im Umgang mit schizophrenen Patienten. Fortschritte im Umgang mit schizophrenen Patienten
353
372
.
Meredith Hanson, Thomas H. Kramer & William Gross. (1990) Outpatient treatment of adults with coexisting substance use and mental disorders. Journal of Substance Abuse Treatment 7:2, pages 109-116.
Crossref
Joachim ZeilerJoachim Zeiler. 1990. Schizophrenie und Alkohol. Schizophrenie und Alkohol
136
150
.